FDA Inspection 964885 — Department Of Defense - Army

Department Of Defense - Army — FEI 2977443

The FDA completed an inspection of Department Of Defense - Army on Mar 28, 2016 in Tripler Army Medical Center, HI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 28, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tripler Army Medical Center, HI (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.